Hero image with Pittsburgh background pittplusme.org/study/1992

STUDY BASICS

Have you been diagnosed with congenital adrenal hyperplasia (CAH)? You may be able to participate in a study to assess if a study drug called crinecerfont is effective in lowering the daily glucocorticoid dose that CAH patients need to control symptoms. Participation will last about 20 months and includes 21 study visits. Compensation is provided. Travel reimbursement may also be provided.


IRB:
  20200122 - A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Adult Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment

Age Range
AGE:   18 and up

Duration DURATION:  Up to 20 months
VISITS:  21 (some may be completed at home)

Location LOCATION: 
UPMC Children’s Hospital of Pittsburgh - Lawrenceville
Compensation COMPENSATION: 

$100 per completed study visit; travel reimbursement may be provided

Phone Number PHONE NUMBER:
1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In
Search Icon pittplusme.org/study/1992
OR
Phone Number PHONE NUMBER:
1-866-438-8230

PittPlusMe.org 1-866-438-8230 PittPlusMe@pitt.edu
@PittPlusMe share tweet